Company intelligence / Profile preview
Stadmed
- Ownership
- Private
- Employees
- ~200
- Development stage
- Other
Overview
Stadmed is a long-established Indian pharmaceutical manufacturer producing branded and generic medicines for a range of indications. Its commercial products, including Alkasol, Pulmocod, Aminozyme, and Entrozyme, are well-known in the Indian market and continue to see strong clinical adoption.
- Therapeutic areas
- EndocrinologyPsychiatryInfectious DiseasesGastroenterologyCardiovascularNeurology
- Modalities
- Small moleculeEnzymeNutritional supplement
- Industry
- Biotech
Drug pipeline
6 assets5 more assets in the full pipeline.
Beyond the preview
Go deeper on Stadmed.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Stadmed.